Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial.
第一作者:
Arun V,Ravindran
第一单位:
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. arun_ravindran@camh.net
作者:
医学主题词
成年人(Adult);抗抑郁药(Antidepressive Agents);中枢神经系统刺激剂(Central Nervous System Stimulants);抑郁症, 更年期(Depressive Disorder, Major);精神障碍诊断和统计手册(Diagnostic and Statistical Manual of Mental Disorders);双盲法(Double-Blind Method);药物协同作用(Drug Synergism);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);人类(Humans);男(雄)性(Male);哌醋甲酯(Methylphenidate);中年人(Middle Aged);疾病严重程度指数(Severity of Illness Index)
DOI
10.4088/jcp.v69n0112
PMID
18312042
发布时间
2022-03-18
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



